Tuesday 23 October 2012

Enzalutamide is a drug that helps men with advanced stages of prostate cancer live longer.  The good news is it helped the men live 37% longer than without the pill.  However, this comparison increased their time from 13.6 months to 18.4 months.  Also, the drug will cost $6,000 USD per month.

While survival rate can be deceiving, the cost to the patient is very high.  Tests are being done to use the drug more efficiently so as to administer it sooner, so the drug could potentially increase the survival rate even more.

Even if the drug could be used in a different way, the cost may say the same.


For the full article, visit http://www.msnbc.msn.com/id/48679807/ns/health-mens_health/

What do you think about this? What would you do if you were a patient, take it or not take it?

No comments:

Post a Comment